Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 26 | Weitzel Gregory ThomasCFO | Tax withholding | F | $113K 9,027 sh | Jan 21, 2026 |
| 25 | Patil Neena MEVP & Chief Legal Officer | Disposition to issuer | D | $561K 3,275 sh | Jan 21, 2026 traded Jan 16, 2026 |
| 25 | Bluestone JeffreyDirector | Open-market sale · 10b5-1 plan | SELL | $618K 5,000 sh | Jan 21, 2026 traded Jan 20, 2026 |
| 23 | Weitzel Gregory ThomasCFO | Grant or award | A | — 9,003 sh | Jan 21, 2026 traded Jan 16, 2026 |
| 23 | Rogers Michael J.SVP, Chief Accounting Officer | Grant or award | A | — 825 sh | Jan 21, 2026 traded Jan 16, 2026 |
| 23 | Kovac MilanDirector | Grant or award | A | — 577 sh | Jan 21, 2026 traded Jan 16, 2026 |
| 23 | Henderson Mary ElizabethSVP, Technical Operations | Grant or award | A | — 10.1K sh | Jan 21, 2026 traded Jan 16, 2026 |
| 23 | Smith DironEVP, Chief Financial Officer | Option exercise | M | — 1,359 sh | Jan 21, 2026 traded Jan 17, 2026 |
| 23 | Meade Christopher J.General Counsel and CLO | Grant or award | A | — 2,500 sh | Jan 21, 2026 traded Jan 16, 2026 |
| 23 | Cree BrianPresident | Open-market sale · 10b5-1 plan | SELL | $384K 19.8K sh | Jan 21, 2026 traded Jan 16, 2026 |
| 23 | Stephens JimPresident, CRM & Neuro | Option exercise | M | — 748 sh | Jan 21, 2026 traded Jan 17, 2026 |
| 23 | Lord RachelSenior Managing Director | Grant or award | A | — 2,339 sh | Jan 21, 2026 traded Jan 16, 2026 |
| 23 | Johnston James DavidExecutive VP, GC, CCO and Secy | Option exercise | M | — 10.8K sh | Jan 21, 2026 traded Jan 16, 2026 |
| 23 | Moore MichaelPresident | Option exercise | M | — 26.9K sh | Jan 21, 2026 traded Jan 17, 2026 |
| 23 | Heller CarolineSenior Managing Director | Grant or award | A | — 1,196 sh | Jan 21, 2026 traded Jan 16, 2026 |
| 23 | Small MartinCFO & Senior Managing Director | Grant or award | A | — 4,348 sh | Jan 21, 2026 traded Jan 16, 2026 |
| 23 | Nasser Amin H.Director | Grant or award | A | — 214 sh | Jan 21, 2026 traded Jan 16, 2026 |
| 23 | Murphy KathleenDirector | Grant or award | A | — 214 sh | Jan 21, 2026 traded Jan 16, 2026 |
| 22 | Mat IshbiaDirector, President and CEO, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $3.82M 632.9K sh | Jan 21, 2026 traded Jan 16, 2026 |
| 22 | Moore MichaelPresident | Tax withholding | F | $63K 8,548 sh | Jan 21, 2026 traded Jan 17, 2026 |
| 22 | Mills Desmond JSVP & Chief Accounting Officer | Tax withholding | F | $84K 1,007 sh | Jan 21, 2026 traded Jan 18, 2026 |
| 22 | Johnston James DavidExecutive VP, GC, CCO and Secy | Tax withholding | F | $78K 2,923 sh | Jan 21, 2026 traded Jan 16, 2026 |
| 22 | Weitzel Gregory ThomasCFO | Tax withholding | F | $91K 7,260 sh | Jan 21, 2026 traded Jan 16, 2026 |
| 21 | Stephens JimPresident, CRM & Neuro | Option exercise | M | — 758 sh | Jan 21, 2026 traded Jan 19, 2026 |
| 21 | Landman YoavDirector, CHIEF TECHNOLOGY OFFICER | Open-market sale · 10b5-1 plan | SELL | $1.21M 21.1K sh | Jan 21, 2026 traded Jan 16, 2026 |
| 21 | Buss Jessica EDirector, Chief Executive Officer | Disposition to issuer | D | — 1.59M sh | Jan 21, 2026 traded Jan 19, 2026 |
| 21 | DeSantis Deborah10% Owner | Other acquisition or disposition | J | $4.65M 120.0K sh | Jan 21, 2026 traded Jan 21, 2026 |
| 21 | DeSantis Dean10% Owner | Other acquisition or disposition | J | $4.65M 120.0K sh | Jan 21, 2026 traded Jan 21, 2026 |
| 21 | DeSantis Deborah10% Owner | Other acquisition or disposition | J | $4.65M 120.0K sh | Jan 21, 2026 traded Jan 20, 2026 |
| 21 | Gerrity Robert WDirector, Chief Executive Officer | Open-market sale · 10b5-1 plan | SELL | $877K 45.5K sh | Jan 21, 2026 traded Jan 20, 2026 |
| 21 | Milmoe William H.10% Owner | Other acquisition or disposition | J | $4.65M 120.0K sh | Jan 21, 2026 traded Jan 21, 2026 |
| 21 | Landman YoavDirector, CHIEF TECHNOLOGY OFFICER | Open-market sale · 10b5-1 plan | SELL | $1.37M 23.5K sh | Jan 21, 2026 traded Jan 16, 2026 |
| 21 | Wagner ScottDirector | Option exercise | M | — 31.4K sh | Jan 21, 2026 traded Jan 21, 2026 |
| 21 | DeSantis Dean10% Owner | Other acquisition or disposition | J | $4.65M 120.0K sh | Jan 21, 2026 traded Jan 20, 2026 |
| 21 | Pearce SamanthaEVP, Chief Commercial Officer | Tax withholding | F | $274K 1,599 sh | Jan 21, 2026 traded Jan 16, 2026 |
| 21 | Gerrity Robert WDirector, Chief Executive Officer | Open-market sale · 10b5-1 plan | SELL | $723K 36.8K sh | Jan 21, 2026 traded Jan 21, 2026 |
| 21 | Milmoe William H.10% Owner | Other acquisition or disposition | J | $4.65M 120.0K sh | Jan 21, 2026 traded Jan 20, 2026 |
| 21 | Stephens JimPresident, CRM & Neuro | Option exercise | M | — 758 sh | Jan 21, 2026 traded Jan 19, 2026 |
| 21 | Bui AndyVP, CHIEF ACCOUNTING OFFICER | Grant or award | A | — 6,522 sh | Jan 21, 2026 traded Jan 20, 2026 |
| 20 | Clifford Katherine LeeChief Leadership & HR Officer | Open-market sale · 10b5-1 plan | SELL | $17K 60 sh | Jan 21, 2026 traded Jan 20, 2026 |